Delayed release dexlansoprazole in the treatment of GERD and erosive esophagitis

Although proton pump inhibitors (PPI) have a record of remarkable effectiveness and safety in the management of gastroesophageal reflux disease (GERD), several treatment challenges with PPI have emerged. Dexlansoprazole MR is the (R)-enantiomer of lansoprazole contained in a formulation that produce...

Descripción completa

Detalles Bibliográficos
Autores principales: Wittbrodt, Eric T, Baum, Charles, Peura, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108635/
https://www.ncbi.nlm.nih.gov/pubmed/21694835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3108635/
https://www.ncbi.nlm.nih.gov/pubmed/21694835

Ejemplares similares